NCT00173862View on ClinicalTrials.gov

Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2000

Study Completion Date

June 30, 2006

Conditions
Transitional Cell Carcinoma
Interventions
DRUG

Gemcitabine, Ifosfamide

Trial Locations (1)

100

Department of Oncology , National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT00173862 - Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC | Biotech Hunter | Biotech Hunter